XBP Global Holdings Earnings Call Transcripts
Fiscal Year 2026
-
The meeting confirmed a quorum and proceeded with the election of directors, ratification of the auditor, and approval of executive compensation. All proposals passed, and stockholders recommended annual Say on Pay votes.
-
Revenue and EBITDA declined year-over-year due to restructuring, but gross margin improved and pipeline momentum is strong, especially in public sector and healthcare. Strategic alternatives are being explored to unlock value, with automation driving operational efficiencies.
Fiscal Year 2025
-
Revenue and EBITDA declined year-over-year due to restructuring and client exits, but gross margins improved from automation and AI initiatives. New sales momentum is evident, with strong Q4 bookings and a growing pipeline, positioning for margin expansion in 2026.
-
A recent acquisition expanded operations to 20 countries, stabilizing revenues and improving margins through AI-driven automation. Multi-year contracts in public sector and healthcare are driving growth, with refinancing plans set to reduce interest costs and further boost cash flow.
-
Q3 2025 pro forma revenue fell 18.1% year-over-year to $220.4M, but gross margin and adjusted EBITDA improved due to automation and cost discipline. The acquisition of Exela BPA expanded scale and capabilities, with new contracts and a strong client base supporting future growth.